A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio
Authors
Mulholland, P. J.Brown, N. F.
McBain, Catherine A
Brazil, L.
Peoples, S.
Jefferies, S.
Harris, F.
Plaha, P.
Vinayan, A.
Brooks, C.
Hussain, S.
Dutton, S. J.
Ng, S.
Levy, S.
Coutts, T.
Affiliation
University College Hospital-London, London,Issue Date
2023
Metadata
Show full item recordCitation
Mulholland PJ, Brown NF, McBain C, Brazil L, Peoples S, Jefferies S, et al. A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio. Journal of Clinical Oncology. 2023 Jun;41(17). PubMed PMID: WOS:001043181100019.Journal
Journal of Clinical OncologyDOI
10.1200/JCO.2023.41.17_suppl.LBA2023Additional Links
https://doi.org/10.1200/JCO.2023.41.17_suppl.LBA2023Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1200/JCO.2023.41.17_suppl.LBA2023